Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus

Published:2024 Issue: Volume: Page:
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Zhao Zhongchao¹²³^ORCID,Chung Young Hun³⁴^ORCID,Steinmetz Nicole F.¹²³⁴⁵^ORCID

Affiliation:

1. Department of NanoEngineering, University of California, 9500 Gilman Dr, La Jolla, San Diego, CA, 92093, USA

2. Center for Nano-ImmunoEngineering, University of California, 9500 Gilman Dr, La Jolla, San Diego, CA, 92093, USA

3. Moores Cancer Center, University of California, 9500 Gilman Dr, La Jolla, San Diego, CA, 92093, USA

4. Department of Bioengineering, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA

5. Department of Radiology, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA

Abstract

We have developed nanoparticle formulations targeting M2 macrophages for cancer immunotherapy by conjugating high-affinity binding peptides to cowpea mosaic virus as an immunostimulatory adjuvant.

Funder

National Cancer Institute

National Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MA/D3MA00820G

Reference46 articles.

1. Releasing the Brakes on Cancer Immunotherapy

2. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

3. Acquired Resistance to Immune Checkpoint Inhibitors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP